fluoxetine has been researched along with phosphocreatine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, BM; Frederick, Bd; Hennen, J; Henry, ME; Kaufman, MJ; Renshaw, PF; Schmidt, ME; Stoddard, EP; Villafuerte, RA | 1 |
Fiedler, KK; Hellem, TL; Jeong, EK; Kondo, DG; Renshaw, PF; Shi, X; Sung, YH | 1 |
Achten, E; Cambron, M; Debruyne, J; Laureys, G; Reynders, T; Reyngoudt, H; Ribbens, A | 1 |
Cao, X; Chen, Y; Gao, T; Ou, CQ; Shen, X; Tan, S; Zang, W; Zhao, L | 1 |
4 trial(s) available for fluoxetine and phosphocreatine
Article | Year |
---|---|
Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study.
Topics: Adult; Brain Mapping; Choline; Depressive Disorder, Major; Female; Fluoxetine; Gyrus Cinguli; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Spectroscopy; Paroxetine; Phosphocreatine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Syndrome | 2003 |
Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study.
Topics: Adolescent; Antidepressive Agents; Creatine; Depressive Disorder; Depressive Disorder, Major; Female; Fluoxetine; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Phosphocreatine; Phosphorus; Radionuclide Imaging; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2011 |
Targeting phosphocreatine metabolism in relapsing-remitting multiple sclerosis: evaluation with brain MRI,
Topics: Adult; Benzofurans; Brain; Double-Blind Method; Female; Fluoxetine; Gray Matter; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis, Relapsing-Remitting; Neuroprotective Agents; Organ Size; Phosphocreatine; Phosphorus Isotopes; Protons; Treatment Outcome; White Matter | 2018 |
Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study.
Topics: Adenosine Triphosphate; Administration, Intravenous; Administration, Oral; Adolescent; Adult; Affect; Aged; Antidepressive Agents, Second-Generation; China; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Feasibility Studies; Female; Fluoxetine; Humans; Male; Middle Aged; Patient Health Questionnaire; Phosphocreatine; Pilot Projects; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Young Adult | 2019 |